TIME FOR LIFE

ERLOTINIB

  • Receptor tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR)
  • Is used as a first-line treatment of metastatic non-small cell lung cancer; pancreas cancer treatment
  • Erlotinib using can increase the life expectancy of these patients more than 6 months compared to standard chemotherapy regimes platinum-drugs